English
Deutsch
Français
Nederlands
Español
Reset. Heal. Grow.
The Argentine Psychoanalyst Who Took Ayahuasca to the Couch in 1959
Most of the names that get repeated in the current wave of psychedelic history belong to men, and most of them lived north of the equator. So it's worth slowing down for a figure who tends to get edited out of the story: a woman in Buenos Aires who, in the late 1950s, was running LSD-assisted group sessions with food and music in the room — and who flew into the Amazon in 1959 to drink ayahuasca with curanderos before almost anyone in Western medicine had even heard the word. Her name was Luisa Agusta Rebeca Gambier de Álvarez de Toledo. Her colleagues called her Rebe. She was the first woman to preside over the Argentine Psychoanalytical Association, and she happens to have written one of the earliest scientific reports on ayahuasca published outside the Amazon. For readers interested in the deep roots of plant medicine and psychedelics in clinical practice — and how master plants found their way into the modern conversation about addiction, trauma, and soul exploration — her story is essential reading. To understand why Argentina, of all places, became fertile ground for early psychedelic experimentation, you have to understand what the city looked like in the 1940s. After the Spanish Civil War and then the Second World War, Buenos Aires absorbed waves of European intellectuals, doctors, artists, and analysts fleeing fascism. The Argentine Psychoanalytical Association was founded in 1942 in that hothouse of imported ideas, and Freud, Klein, Lacan, and the British object-relations school all got argued over at the same dinner tables. Álvarez de Toledo trained as a physician and got drawn into psychoanalytic theory while still in medical school. By the early 1950s she was working at the Hospicio de la Mercedes, the country's first psychoanalytic institution, alongside the legendary psychiatrist Enrique Pichon-Rivière. Her 1954 paper on the emotional life of the therapist during the session — what we'd now recognise as a precursor to modern conversations about countertransference and presence — is still cited as a classic. She wasn't a fringe figure. She was the establishment. And then, almost as soon as she became APA president in 1956, she organised a working group to experiment with LSD. Sandoz was the source. A representative from the Swiss company supplied the substance and the existing clinical literature, which by then included scattered reports from Europe and a handful of American hospitals. She wasn't even the first in Argentina to publish on it — the psychiatrist Alberto Tallaferro had already documented more than a thousand sessions with LSD and mescaline in 1956, and he sat in on her early work. What's striking, reading her four published articles from 1957 to 1960, is how modern the protocol sounds. The therapists drank the medicine themselves first — sometimes LSD, sometimes mescaline — and wrote up their own experiences in the scientific papers. They considered self-experimentation an ethical prerequisite, not a sideshow. You couldn't sit with a patient through something you hadn't met yourself. She brought two things into the session that weren't standard psychoanalytic furniture: She also refused to leave patients alone. The therapist's job was to build and hold a strong connection — what she'd been arguing for years was the heart of any good analytic relationship, just intensified by the medicine. By 1960, after three years of work, she was running twelve groups, around a hundred patients in total, and concluded that group psychotherapy combined with LSD was, in her words, a really effective method. She also insisted on two facilitators per group, so that if someone went into what she called a generalised psychopathic episode, one therapist could step out with them while the other held the room. Sound familiar? It's the same staffing logic any honest psychedelic retreat uses today. Then came the part of her story that almost nobody outside specialist circles knows. In 1959, Álvarez de Toledo travelled into the Amazon jungle to drink ayahuasca with curanderos. In 1959. Before Burroughs and Ginsberg's Yage Letters had reached a wide audience. Before the Santo Daime had crossed any borders. Before the word ayahuasca meant anything at all to most physicians. She published her account in 1960 as one of the very first scientific articles on the brew. Her method was a hybrid that feels surprisingly contemporary — part ethnography (she wanted to document what the curanderos actually did, in their own terms), part clinical evaluation (she wanted to know whether this could do therapeutic work). She researched how the curanderos understood the experience and what they expected of participants before she ever lifted a cup. She ended up trying ayahuasca twice with two different curanderos. The first ceremony she dismissed almost immediately — the brew had been cut with gasoline (yes, really), the room was small and dirty, the village too close and too noisy. The second time was different. Held in the forest. A curandero who treated her as a colleague and refused payment. She asked specifically to be included in a local group ceremony so she could observe how these things actually unfolded in their natural setting, rather than as a private demonstration for a foreign doctor. Her own description of the experience is worth quoting because it's so unguarded — a trained analyst writing without any of the defensive posture you'd expect from a 1960 medical journal: The curandero himself vomited, she noted, as an invitation to the others. This worried her — in her psychoanalytic frame, vomiting and diarrhea were defensive responses to the fear of the unknown. The villagers reassured her. Then her own nausea came, dry and without release, and the trance took her over completely beneath the icaros being sung around her. Walking back to the village afterwards, she described seeing the earth and plants and her own body emitting bluish waves spreading outward, lights appearing and going out around her, a deep euphoria in the presence of such beauty. She walked, uncertain, on a very soft earth. Her clinical summary afterwards was characteristically honest: she felt the observation had been disturbed by her own defenses and by her lack of the ritual language, which prevented her from fully grasping what the masters were actually doing therapeutically. She wasn't claiming mastery. She was naming the gap. It's easy to read history like this as colourful background, but it bears directly on choices people are making right now. The current wave of interest in plant medicine for addiction, depression, and trauma sometimes presents itself as brand new. It isn't. Álvarez de Toledo and her colleagues had already worked out, three generations ago, several of the principles that any reputable retreat should still be following: What strikes me, reading her papers now, is how much of the current psychedelic-assisted therapy world is reinventing wheels she'd already drawn. The careful preparation. The continuous presence. The integration sessions. The respect for group dynamics. She got there in heels in Buenos Aires in 1957 and confirmed it under icaros in the Amazon in 1959. Álvarez de Toledo died in 1990, just as MAPS was being founded in California and the modern revival was beginning to stir. She didn't live to see ayahuasca become an international phenomenon, didn't watch psilocybin trials at Johns Hopkins, didn't read the headlines about ibogaine for opioid addiction. But the through-line is hers as much as anybody's: a working clinician who took these substances seriously as therapeutic tools, treated traditional knowledge as knowledge rather than folklore, and held herself to the same rigour with mescaline and ayahuasca that she held herself to with her analytic patients. For anyone weighing whether to sit in ceremony, her example offers something more useful than enthusiasm. It offers a standard. Does the place you're considering treat preparation seriously? Are the facilitators trained, present, and willing to talk about their own relationship with the medicine? Is there real integration support afterwards? Those questions aren't new. They've just been waiting for us to ask them again. If reading this has sharpened your curiosity, a range of carefully vetted ayahuasca and plant-medicine retreats can be explored on our marketplace here — a useful place to start when you want to see what genuinely thoughtful facilitation looks like in practice today.
Choosing a Plant Medicine Retreat in Peru: An Honest Guide for First-Timers
Peru keeps pulling people in. Not the tourists snapping photos at Machu Picchu — I mean the other kind. The ones who fly into Lima with a half-formed question they can't quite articulate, a stuck feeling they've been carrying for years, maybe an addiction or a depression that talk therapy hasn't touched. They come for ayahuasca. They come for huachuma. They come for the master plants. And most of them have no idea what they're signing up for. If that's you — or somewhere near you — this is the kind of guide I wish I'd had before my first trip into the Amazon. Peru is genuinely one of the world's most important destinations for plant medicine work, but it's also a country where the word shaman gets stamped on a lot of business cards. Knowing the difference between a real lineage holder and a guy with a feathered hat matters. So does knowing what kind of retreat actually fits what you're carrying. The short answer: lineage. Ayahuasca has been brewed and consumed in the western Amazon for at least several centuries, and the Shipibo-Conibo, Shuar, and other Amazonian peoples have refined ceremonial frameworks around it that simply don't exist elsewhere. When you sit in a maloca outside Iquitos or in the high jungle near Tarapoto, you're not at a wellness pop-up — you're inside a tradition with its own grammar. The geography matters too. Coastal desert, Andean highlands above 11,000 feet, and dense lowland jungle all sit within a single country. Different plants thrive in different zones. Ayahuasca and the master plant dietas belong to the jungle. San Pedro (huachuma) belongs to the Andes. Knowing where you're going changes everything about what the experience will feel like — humidity, altitude, mosquitoes, the sound of the night. There's also a legal reality worth naming. Ayahuasca is recognized as cultural heritage in Peru and can be served openly in ceremonial contexts, which means reputable centers operate above-board rather than in the shadows. That alone changes the safety calculus compared to a basement ceremony in a country where everything's illegal. Forget the Instagram version. A genuine ayahuasca retreat is mostly quiet. You arrive, you settle in, you eat bland food (no salt, no sugar, no pork, no spice — the dieta is real and it starts before the first ceremony). You meet the facilitators. You fill out a medical form that asks about SSRIs, heart conditions, and psychiatric history, and if the center doesn't ask, leave. Ceremonies usually run from after sunset until somewhere around three or four in the morning. You sit or lie on a mat in a circular wooden structure called a maloca. The curandero or curandera sings icaros — medicine songs that shape the visions and hold the space. You drink a small cup of something that tastes like burnt earth and bitter regret. Then you wait. Within forty minutes or so, the medicine starts to move. What happens next is impossible to summarize honestly. People purge. People weep. People meet versions of themselves they've been avoiding for decades. Some nights are profound. Some nights are confusing and uncomfortable and seem to do nothing — until three weeks later when you realize you stopped doing the thing you've been doing for fifteen years. That's how plant medicine often works. Sideways. Ayahuasca gets the headlines, but it's not the only medicine working in Peru. A few worth knowing about: If you're researching plant medicine for addiction recovery specifically, ayahuasca and huachuma both have decades of anecdotal reports and a growing handful of preliminary studies behind them. They aren't magic bullets. People I've spoken with who got real traction with their drinking, their opiates, or their compulsive patterns almost always combined ceremony with serious aftercare — therapy, sober community, lifestyle overhaul. The retreat is the catalyst, not the cure. Pricing varies wildly, and the cheapest option is almost never the right one. A reasonable range for a reputable 7-to-10-day ayahuasca retreat in Peru runs roughly $1,200 to $3,500, including lodging, meals, ceremonies, and integration sessions. Master plant dietas often cost a bit more per day because of the extended supervision. Flights to Lima and onward to Iquitos, Tarapoto, or Cusco add several hundred dollars on top. What you're paying for, at a good center: licensed facilities, trained facilitators, medical screening, a curandero with actual lineage, vetted brew (sourced and prepared correctly, not cut with toxic additives), and proper integration support afterward. What you save by going cheap: usually exactly those things. I've heard enough stories of people drinking sketchy brew in roadside operations to feel comfortable telling you flatly — don't. This is the part of the conversation that doesn't happen often enough. The plant medicine space attracts good people, and it attracts predators. Knowing the difference protects you. Most centers send you a preparation document with the dieta guidelines. Follow them. The standard is two to four weeks beforehand: no alcohol, no recreational drugs, no pork, no aged cheese, no fermented food, no spicy food, minimal salt and sugar, no sex in the final week. It sounds extreme. It's there for pharmacological reasons (MAOI interactions are real) and for ceremonial ones. The psychological prep matters just as much. Spend time with the question of why you're going. Write it down. Not as a wish list — the medicine is not a vending machine — but as honest reflection on what's pulling you toward this. People who arrive with a clear, sincere intention generally have more coherent experiences than people who show up just curious. Practical stuff: bring a headlamp with a red-light setting, loose clothing in layers, a journal, bug spray that doesn't contain DEET (the jungle centers usually advise natural repellents), and earplugs. Leave the laptop. Tell someone at home where you'll be and roughly when you'll be reachable again. Here's the thing about plant medicine. The ceremony is loud and the integration is quiet, and the integration is where the actual change either happens or doesn't. People come back from Peru radiant for about ten days. Then real life shows up — the same job, the same partner, the same patterns waiting patiently at the door. Without a practice to bring the insights into ordinary time, the experience tends to fade into a beautiful memory that doesn't actually move the needle. That's the sad version. The other version, the one I've seen work, involves continued therapy, a regular meditation or somatic practice, community with other people who've done this work, and a willingness to be patient with yourself for months, not days. If something in this piece is calling to you, sit with it for a while before booking anything. Read more. Talk to people who've been. When you're ready to compare specific options, a curated selection of ayahuasca, huachuma, and master plant retreats in Peru can be browsed on our marketplace here. Peru will still be there when you're ready. The plants aren't going anywhere.
What the DEA Got Wrong About Ayahuasca: Inside a Flawed Federal Report
A 33-page internal document. Two years of foot-dragging before it saw daylight. And conclusions that, frankly, read less like a scientific review and more like a brief written by someone who had already decided how the story ends. That's the short version of the Drug Enforcement Administration's report on ayahuasca — a paper titled Ayahuasca: Risks to Public Health and Safety, dated July 2020, finally pried loose through a Freedom of Information Act request by the Chacruna Institute and the Church of the Eagle and the Condor. If you're a reader who's been quietly considering an ayahuasca retreat, weighing whether plant medicine might help with depression, addiction, or some stuck place in your life, this document matters. Not because it's accurate. Because it shapes the legal and cultural weather around the medicine you're researching. Let's walk through what the report actually says, where it bends the evidence, and what the broader scientific record looks like when you read it without an agenda. Ayahuasca occupies a strange legal space in the United States. The Supreme Court ruled in 2006 that the União do Vegetal — one of the syncretic Brazilian churches that uses the brew as a sacrament — has a constitutional right to do so under religious freedom protections. Santo Daime won similar protections shortly after. But for newer congregations like the Church of the Eagle and the Condor, getting recognition is a grind, and federal documents like this one are quietly cited to justify keeping the brakes on. So when an agency with enforcement power produces a paper that looks scientific — footnotes, citations, clinical language — it carries weight far beyond its actual rigor. That's what makes the contents worth picking apart. Here's where the report gets specific. It cites the American Association of Poison Control Centers, which logged 538 ayahuasca-related emergency calls between 2005 and 2015. Of those, 150 involved ICU or semi-ICU stays. There were 28 intubations, seven respiratory arrests, and four cardiac arrests. A separate request covering 2012 to 2017 turned up 341 ayahuasca-linked cases and 122 involving DMT specifically. Those numbers sound scary in isolation. Read them again with the timeframe attached. We're talking about a decade. Across an entire country. During years when ayahuasca use was expanding rapidly through both religious and underground channels. And — this is the part the DEA buries on the same page — the agency itself acknowledges that 43% of the cases involved ayahuasca taken alongside other substances. Which means there's no clean way to say the medicine caused the harm. For comparison, the same poison control system fields roughly two million calls every year for everything from accidental Tylenol overdoses to kids eating houseplants. The ayahuasca slice is, statistically, a rounding error. None of which is to say risk doesn't exist — it does, and we'll get to it — but the framing matters. The pattern, once you see it, repeats throughout the document. Cite a study. Acknowledge its findings are modest or inconclusive. Then pivot to a hypothetical worst-case scenario and treat it as the takeaway. A few examples: What's striking isn't that the report mentions risks. Risks deserve mention. What's striking is the asymmetry. When the data points toward danger, the language is confident. When it points toward benefit, suddenly the studies are too small, the controls too weak, the population too narrow. Here's the omission that should bother anyone who cares about honest science. The report is dated July 2020. A landmark study had been published the year before: the first placebo-controlled clinical trial of ayahuasca for treatment-resistant depression, run by Dráulio de Araújo's team at the Federal University of Rio Grande do Norte. Twenty-nine participants. Real methodology. Promising results. It's not in the DEA bibliography. Not cited, not addressed, not refuted. Just absent. You can draw your own conclusions about why a federal review of ayahuasca's therapeutic potential, written in 2020, would simply leave out the most rigorous clinical trial on the subject. The broader academic literature tells a different story than the one the DEA constructs. Recent reviews — including a thorough survey by Brazilian researchers Maia, Daldegan-Bueno, Wießner, de Araújo, and Tófoli in European Neuropsychopharmacology — conclude that the strongest evidence for ayahuasca's therapeutic effects lies in two areas: depression and substance use disorders. Which, if you're researching plant medicine because you're struggling with one of those things, is exactly the conversation you're trying to have. A review published in Human Psychopharmacology by James, Keppler, Robertshaw, and Sessa covers much of the same source material as the DEA report — but reads like it was written by people who actually wanted to understand the medicine rather than build a case against it. Their conclusions are worth quoting because they sound like the kind of thing a thoughtful retreat facilitator would tell you: screening matters. Preparation matters. People with personal or family histories of psychosis carry real elevated risk and should probably not drink ayahuasca. But for healthy individuals using the brew in a structured ceremonial context, the data simply does not support the alarmist framing. Incidence of psychosis in ayahuasca drinkers is reported at under 0.1% of consumers. The União do Vegetal alone has roughly 22,000 members who drink ceremonially every two weeks, year after year, with very rare serious adverse events. That's the lived data. Decades of it. Across continents. None of this means ayahuasca is harmless or right for everyone. The honest version is more nuanced: The DEA's report will probably keep circulating in policy circles for years. Documents like that have long half-lives. But you don't have to take its framing at face value. The science is out there, the ceremonial tradition is older than most modern nations, and the safety record — when the medicine is used the way it has been used for centuries — is considerably better than the prohibitionist paper would have you believe. If, after sitting with all of this, you want to take the next step and actually look at structured options, curated ayahuasca retreats can be browsed on our marketplace here. Read carefully, ask the screening questions back, and trust the slow process of choosing well.
Inside the Ayahuasca Ceremony: What Western Seekers Actually Experience
There’s a particular kind of question I get asked over and over by people considering their first ayahuasca retreat. It’s not does it work? — that’s the easy one. It’s what is it actually like? What happens in the body, in the mind, in those long hours between the first sip and sunrise? And does the experience of a Western traveller in the upper Amazon look anything like the textbook descriptions of plant medicine and master plants we read about online? A few years back, a group of researchers sat down with nine foreign participants at a retreat centre in Peru and asked them, in the gentlest possible way, to describe what they’d just gone through. No leading questions. No checklists. Just: tell me about your ceremony. The patterns that emerged are some of the most useful reading I can recommend to anyone weighing a booking decision — not because they tell you what will happen to you, but because they sketch the shape of what tends to happen across very different people in the same ritual container. Here’s what stood out, and why it matters if you’re considering ayahuasca for addiction, depression, trauma, or one of those stuck life patterns nothing else seems to touch. The setup was straightforward. Nine Western participants attended six ceremonies over the course of a traditional retreat in the Peruvian Amazon. The morning after the second ceremony — close enough that memory was vivid, far enough that they’d slept on it — researchers conducted open narrative interviews. People were invited to talk freely, and the transcripts were combed for recurring themes using qualitative content analysis. What’s nice about this approach is that it doesn’t force the experience into a pre-shaped box. Quantitative studies on psychedelics are useful — we need them — but they tend to flatten the texture of what people actually live through. Numbers can tell you that depression scores dropped at week five. They can’t tell you about the hour you spent crying about your father, or the strange certainty that a forest of geometric vines was teaching you something about your marriage. Three big buckets emerged from the interviews: what happened during the ceremony itself, how participants made sense of the process afterwards, and how prepared (or unprepared) they felt going in. Inside the first bucket, the researchers found a familiar list — physical symptoms, visions, received messages, emotional reactions, cognitive shifts, and the meaning people attached to all of it. One of the things that surprises new drinkers most is how physical ayahuasca is. About an eighth of everything participants talked about in the study was somatic — body sensations, temperature shifts, tingling, pressure, nausea, the famous purge. This isn’t a footnote to the psychedelic experience; for many people, it is the experience. Veterans of the ceremony often describe the onset as something foreign moving in — an energy, a presence, a current that takes up residence in the nervous system. That language sounds woo-woo on the page, but it’s remarkably consistent across cultures and decades of reporting. And brain imaging gives us a partial explanation: ayahuasca lights up regions like the anterior insula and paralimbic cortex, areas tied to interoception (your sense of what’s happening inside your body) and emotional processing. Disruption in these same regions has been linked to depression, addiction, PTSD, and complex trauma. So when the medicine cranks up your felt sense of your own body, it’s plausibly working on the exact circuitry that trauma has muted. And then there’s the purge. Vomiting, sometimes diarrhoea, occasionally both — what curanderos call la purga. The harmala alkaloids in the brew interact with stomach enzymes, and the DMT acts on serotonin receptors in your gut. The chemistry is real. But in the tradition, this isn’t a side effect to be managed; it’s the medicine doing its job. Participants in the study, and in pretty much every ayahuasca account I’ve read, describe the purge as something that releases — old grief, old anger, a knot they didn’t know they’d been carrying since they were nine. Some Amazonian lineages call it getting well. After enough ceremonies, you start to understand why. Every single person in the study reported significant emotional release. Not a polite tear or two — actual catharsis. Researchers sorted these into three rough categories: pleasant, unpleasant, and what they called hedonistic. The most interesting pattern was the sequence. Unpleasant emotional states tended to be followed by pleasant ones, as if the medicine were walking people through a difficult room and then opening a window on the other side. This matches something therapists have known for a long time: avoidance keeps pain alive, and contact with it — under the right conditions — is what allows it to move. Ayahuasca seems to dismantle the psychological defences people normally lean on, which is both why it can feel terrifying and why it can be so useful. You can’t intellectualise your way out of what the vine is showing you. You have to feel it. Research with psilocybin has found that what predicts long-term improvement isn’t whether the trip was pleasant — it’s whether the difficult parts got worked through. There’s a concept called emotional breakthrough that closely echoes the old psychoanalytic idea of catharsis: a hard experience, met fully, that resolves into something. Ayahuasca seems to produce these breakthroughs reliably, which is one reason it shows up in conversations about addiction recovery and trauma healing alongside ibogaine and psilocybin-assisted therapy. Participants also described things that sound almost gentle by comparison — heightened self-love, more empathy, the strange experience of meeting themselves with kindness for the first time in years. There’s growing evidence that ayahuasca drinkers score higher on measures of self-acceptance and present-moment awareness, the kinds of qualities that mindfulness-based therapies spend months trying to cultivate. Three of the nine participants reported direct communication with what they described as entities or presences — supportive figures, sometimes recognisable, sometimes not. This is one of the more delicate parts of any honest conversation about ayahuasca. If you’ve never had the experience, it sounds either embarrassing or alarming. If you’ve had it, you know that explaining it to someone who hasn’t is a fool’s errand. What the research is careful about — and what I think any prospective retreat-goer should be careful about too — is the question of what to do with these encounters. Are they projections of the unconscious? Genuine non-human intelligences? Something the Western frame doesn’t have a word for? You don’t need to settle that question to benefit from the experience. What matters, practically, is that the messages tend to feel meaningful to the person receiving them, and that they often connect to whatever the person came into ceremony carrying. Visions, similarly, ranged from the abstract — geometric patterns, lattices of light — to the deeply personal, like watching scenes from one’s own childhood replay with new context. The participants didn’t describe these as entertainment. They described them as instruction. A few honest takeaways from sitting with this material — and from sitting in ceremonies myself. If you’re shopping retreats, the things to look for are surprisingly mundane. Medical screening. A clear policy on antidepressants and other medications. Facilitators who can name their lineage and their teachers without getting cagey. A sensible participant-to-shaman ratio. Aftercare, or at least a real handoff to integration support. Honest cost transparency — and yes, a real ceremony with experienced practitioners is rarely cheap, but exorbitant prices aren’t a quality signal either. Red flags? Anyone promising specific outcomes. Anyone discouraging you from talking to your doctor. Anyone running ceremonies so large that the shaman can’t actually see what’s happening to each person. Anyone framing the medicine as a one-shot fix rather than the start of work you’ll continue on your own. For readers ready to take this further, a range of vetted ayahuasca retreats and other plant-medicine programmes can be browsed on our marketplace here. Sit with the decision; the right time tends to make itself known.
Indigenous Voices on Ayahuasca: What the 4th Brazilian Conference Declared
Something important happened in the Brazilian Amazon a few years ago, and most people sitting down to their first ayahuasca ceremony have never heard about it. Between late September of 2022, on the banks of the Juruá River in Acre, nearly 250 Indigenous representatives from five countries gathered for five days to talk about one thing: what is happening to ayahuasca as it travels out of the forest and into the wider world. They produced a declaration. It's not long, and it's not legally binding, but it lays out — clearly and without much diplomatic softening — how the guardians of this medicine feel about the way the rest of us are using it. If you're researching an ayahuasca retreat right now, this document is worth your attention. It changes how you read marketing copy. It changes what questions you ask a facilitator. It might even change where you decide to go. The Fourth Indigenous Ayahuasca Conference was hosted at the Yorenka Tasorentsi Institute in Marechal Thaumaturgo, organized together with the Organization of Indigenous Peoples of the Juruá River. Around 389 people attended — 244 of them Indigenous, the rest researchers, allies, and invited guests. It was self-financed, which matters: no government grant, no NGO pulling the strings. The list of peoples present reads like a map of the Amazon's living traditions: the Yawanawá, Huni Kuĩ, Shipibo-Konibo, Ashaninka, Shanenawa, Kuntanawa, Yanomami, Guarani Mbyá, and dozens more. Delegations came from Peru, Colombia, Ecuador, Mexico, and Canada — including the Inga and the UMIYAC association of Yagecero physicians, the Kichwa of Sarayaku, the Wixárika, and Anishinaabe representatives from the north. This wasn't a meeting of one tribe speaking for many. It was a chorus. That detail matters because in the broader psychedelic conversation — the conferences in California, the podcast circuit, the glossy retreat brochures — Indigenous voices often get flattened into a single, decorative cameo. Here, the situation was reversed. The people who have been working with this medicine for generations were doing the talking, and the non-Indigenous attendees were largely there to listen. Reading the letter that came out of the plenary on September 29, a few things stand out. The first is the framing of ayahuasca itself. The participants describe it as a vital conductor of life, an ancestral form of knowledge that has survived colonization. Not a substance. Not a tool. Not a wellness intervention. A relationship. From that starting point, the declaration moves through a series of concerns that are, frankly, hard to ignore once you've read them: There's also a striking line about spirituality not being for sale — but capable of being shared, when the sharing happens with what they call profound ethics. That distinction is the whole game. It's the difference between a retreat that respects its lineage and one that's basically extracting it. Here's the practical part. You're probably reading this because you're somewhere on the spectrum between curious and seriously considering plant medicine — maybe for depression, addiction, trauma, or just the slow grinding feeling that something in your life needs to crack open. The declaration doesn't tell you whether to go. But it gives you a much sharper lens for choosing where. A few questions worth asking any retreat you're considering, especially ones that drape themselves in Indigenous imagery: None of these questions are rude. A reputable operation will answer them happily. A sketchy one will get defensive or vague. That tells you almost everything you need to know. Ayahuasca is the most visible of a family of plant medicines often called master plants — alongside tobacco (the real tobacco, not cigarettes), San Pedro, peyote, and the ayahuasca vine itself. The declaration's concerns about commercialization apply to all of them. Demand has exploded over the past decade. So has the price of the vine. So has the number of foreigners flying to Iquitos, Pucallpa, and the Sacred Valley to drink. This isn't automatically bad. The growth of psychedelic interest has funded real clinical research, opened legitimate conversations about addiction recovery and mental health, and given many Indigenous communities a source of income that doesn't involve logging or coca. But it has also produced a parallel economy of inauthentic ceremonies, plagiarized songs, exploitative wage labor for local healers, and the slow erosion of dieta and ceremonial protocols that took centuries to develop. The declaration's authors aren't anti-retreat. They explicitly talk about sharing medicine with non-Indigenous people under the right conditions. What they're against is the version of the boom that treats their cosmology as a commodity to be stripped, packaged, and resold without consent or reciprocity. That's a reasonable position. It's also a useful filter for anyone deciding which retreat deserves their money. One concept that keeps surfacing in conversations with Indigenous leaders is reciprocity — and it's worth understanding before you book anything. Reciprocity doesn't mean tipping the curandero an extra fifty dollars at the end of the week. It means the retreat itself is structured so that value flows back to the source community in a sustained, structured way. Concretely, that can look like: a percentage of retreat fees going to land defense or Indigenous-led reforestation; medicinal plants being cultivated rather than wild-stripped; local apprentices being trained and paid fairly; partnerships with Indigenous organizations that have real decision-making power, not symbolic seats on a board. Some retreats do this. Many don't. A few have started publishing detailed reports about exactly where the money goes, which is a healthy sign. The Indigenous Reciprocity Initiative of the Americas, mentioned in the original conference materials, is one of several efforts trying to formalize this. As a prospective retreat-goer, you don't need to memorize every framework — you just need to ask the people taking your money how they think about giving back, and listen carefully to whether the answer sounds rehearsed or real. The Fifth Indigenous Ayahuasca Conference was scheduled for 2024, and the conversation has only deepened since. The declaration from 2022 still sits there, quietly, waiting for the wider psychedelic world to actually grapple with it. Most retreats don't mention it. Most facilitators have never read it. That's both a problem and an opportunity — because if you raise it in a conversation with a retreat coordinator and they engage thoughtfully, you've learned something important about who you're about to trust with your nervous system. None of this is meant to scare you off. Plant medicine, used with care and in the right setting, has helped a lot of people reckon with addiction, depression, and the kind of stuck patterns that talk therapy can circle around for years without touching. The point is just that the medicine doesn't exist in a vacuum. It comes from somewhere, from someone, and the conditions of its sharing matter — for the integrity of your experience as much as for the people whose ancestors carried it forward. If reading the declaration has shifted something in how you're thinking about all this, a range of carefully vetted ayahuasca retreats — many of them with genuine, documented relationships to Indigenous communities — can be browsed on our marketplace here. Take your time choosing. The retreat that's right for you will still be there next month, and the questions worth asking won't change.
Craving More Stories?
Join our ShopAyahuascaRetreats newsletter for the latest updates on thrilling
destinations and inspirational tales, delivered straight to your inbox!
We value your privacy. Your email address will never be shared or published.
The Ayahuasca Diet Explained: What to Eat and Avoid Before Ceremony
If you've started reading about ayahuasca retreats, you've probably bumped into the word dieta — and the slightly intimidating list of foods you're supposed to drop in the weeks before ceremony. No aged cheese. No fermented things. No pork. No chocolate. (Yes, really, no chocolate.) For a lot of people, that's the first moment the whole thing stops feeling abstract and starts feeling real. You're actually doing this. So let's talk about what the ayahuasca diet actually is, why it exists, and how to follow it without turning your kitchen into a misery zone for a month. This is the same territory anyone serious about plant medicine and master plants ends up walking — whether the goal is addiction recovery, working through depression, or just finally looking honestly at the patterns that have been running the show for too long. The dieta is two things at once, and people often confuse them. The first is a hard-edged medical safety protocol — there are foods and substances that can react badly with the brew, and you genuinely need to avoid them. The second is a softer, older idea from Amazonian tradition: that preparing your body, quieting your habits, and stepping back from stimulation makes you more available to whatever the medicine has to show you. Both layers matter. The medical one keeps you safe. The traditional one shapes the quality of the experience. Skip the first and you risk an unpleasant or dangerous reaction. Skip the second and you're more likely to spend the ceremony processing last week's burrito instead of the things you actually came to look at. Most reputable retreats will hand you a written list of restrictions and a timeline — usually somewhere between two and four weeks before your first ceremony, and continuing for a stretch afterward. The exact length varies. Some traditions are stricter than others. If your retreat hasn't given you a clear list, that's worth a polite question before you arrive. Here's the part that actually matters for safety. Ayahuasca contains MAO inhibitors — specifically, the harmala alkaloids from the Banisteriopsis caapi vine. MAO inhibitors block an enzyme in your body called monoamine oxidase, which normally breaks down certain compounds, including tyramine. Tyramine is a naturally occurring amino acid that shows up in aged, fermented, smoked, and cured foods. Under normal circumstances your body handles it fine. But when MAO is inhibited and you load up on tyramine-rich foods, blood pressure can spike sharply. The medical term is a hypertensive crisis. The practical translation: pounding headache, nausea, and in rare serious cases, something that needs a hospital. This isn't shamanic superstition — it's the same reason people on prescription MAOI antidepressants are handed a similar food list. The other layer is serotonergic. Ayahuasca is powerfully serotonergic, and combining it with other serotonergic drugs (SSRIs, SNRIs, MDMA, certain migraine meds, St John's Wort, tramadol, and more) can trigger serotonin syndrome. That's not a food issue, it's a medication issue — and it's the single most important conversation to have with the retreat's medical screener before you book anything. Don't lie on that form. Don't quietly stop your antidepressants a week before. Talk to a doctor who knows what tapering safely actually looks like. Different lineages and different retreats vary in how strict they are, but the core list is fairly consistent. Here's what almost everyone agrees on: Salt and spice get reduced, not necessarily eliminated. The goal isn't a punishment fast; it's a clean, simple intake that doesn't demand much from your digestion. This part gets lost in the lists of forbidden things. The dieta isn't about deprivation. It's about eating cleanly and simply for a few weeks. Most people land somewhere close to a plant-forward, mildly seasoned, home-cooked rhythm. Good things to lean into: fresh fruit (eaten ripe but not overripe), most vegetables, rice, quinoa, oats, lentils, beans, plain potatoes and sweet potatoes, fresh fish in moderation if your retreat allows it, nuts and seeds in small amounts, herbal teas (chamomile, peppermint, ginger), and plenty of water. Olive oil is fine. Fresh herbs are fine. A little garlic and onion, fine. People often report feeling unexpectedly good a week or two into the diet — clearer mornings, steadier moods, better sleep. That's not the medicine yet. That's just what happens when you stop pouring sugar, caffeine, and alcohol on a nervous system. Take notes. That baseline is useful information. The honest truth: the first week is the hardest. Caffeine withdrawal is real. Social situations get awkward. You'll get invited to a friend's birthday and have to explain why you're drinking soda water. A few things that help: If you slip — a coffee, a glass of wine ten days out — don't spiral. Tell your facilitator honestly when you arrive. They've heard it all. What matters is the last week, and especially the final 72 hours, when the rules tighten and the safety stakes go up. Here's something the food lists don't capture. The diet isn't really about food. It's about practice — about training the part of you that can say no to an impulse for a few weeks, that can simplify, that can pay attention. People who treat the dieta as a chore tend to have a harder ceremony. People who treat it as the first stage of the work tend to walk in already partway home. That's true whether your reason for sitting is addiction recovery, trauma, depression, grief, or just the sense that something in your life has gone quietly stuck. The reduction in stimulation makes room. The simplicity of the meals tunes you down to a frequency the medicine can meet. By the time you're sitting in the maloca on night one, you've already been preparing for weeks, and your body knows it. This is also why the diet continues afterward — usually for at least a few days, sometimes longer. Integration is fragile. Your nervous system is open. A heavy meal, a few drinks, a big argument in the first 48 hours can scramble what's still settling. Treat the post-ceremony window with the same care as the lead-up. If reading this list of restrictions makes you feel something like dread or resentment, that's worth sitting with. The dieta is a small ask compared to what the ceremony itself will ask of you. If a month without coffee and chocolate already feels impossible, it's worth asking yourself what that signal is telling you — and whether now is actually the right time, or whether some groundwork (therapy, a clearer reason for going, a conversation with someone who's done it) might come first. And if it doesn't feel like dread — if it feels more like quiet relief that someone is finally telling you to slow down and eat simply for a few weeks — that's a good sign too. For readers who want to take this further, a range of vetted ayahuasca retreats and ceremonies can be browsed on our marketplace here. Whatever you choose, do the diet honestly. The medicine notices.
Is the Ayahuasca Vine Running Out? The Conservation Story Nobody at Retreats Talks About
If you've spent any time researching ayahuasca retreats, you've probably read the brochures. The reverence for the vine. The lineage of the curanderos. The candlelit maloca three hours into the night. What you've almost certainly not read — and what almost no retreat website wants to bring up — is whether the plant at the center of all this is being harvested faster than the rainforest can grow it. I want to talk about that. Because if you're seriously considering booking an ayahuasca ceremony, you're stepping into a story that's bigger than your own healing. The vine has its own life, its own ecology, and increasingly, its own crisis. None of this should scare you off a retreat. But it should change how you choose one. Ayahuasca is a brew. Usually two plants, sometimes more. The psychoactive punch comes from DMT-containing leaves — most commonly chacruna (Psychotria viridis) or, in parts of Brazil, chaliponga. But the leaves on their own do nothing when you drink them. Your gut breaks the DMT down before it can reach your brain. That's where the vine comes in. Banisteriopsis caapi — caapi, jagube, mariri, depending on where you are — contains harmala alkaloids that switch off the enzyme responsible for that breakdown. Without the vine, no journey. The Quechua word ayahuasca means “vine of the soul,” and it refers both to the plant and to the brew. Among most Amazonian traditions, the vine is considered the elder, the teacher, the actual master plant. The leaves are the voice; the vine is the spirit doing the talking. This matters for conservation because the vine is the slow-growing one. Chacruna grows back like a weed. Caapi takes years — sometimes a decade or more — to reach the maturity that traditional brewers consider proper. You can't simply replant your way out of a shortage in a single season. Western botany has been calling caapi a single species since Richard Spruce described it in 1852. But the people who actually use the plant have always known better. Ayahuasqueros across the Amazon distinguish numerous varieties — tucunacá, caupuri, cielo, trueno, ourinhos, and many more — each with its own appearance, character, and felt effect in ceremony. For a long time, scientists shrugged. Even the legendary ethnobotanist Richard Evans Schultes admitted he couldn't visually tell the varieties apart, even though indigenous brewers could identify them from across a clearing. More recent Brazilian research has started to confirm what traditional knowledge has held all along: the varieties differ in leaf color, gland arrangement, stem nodes, bark, and crucially, in their alkaloid profiles. A 2020 chemistry study found significant variation in harmala content between varieties — which is a polite scientific way of saying yes, they hit different. Why does this matter to a person booking a retreat? Because conservation isn't just about saving the vine. It's about saving the varieties. If commercial harvesting flattens the genetic diversity down to whichever vines are easiest to find and chop, something irreplaceable is lost — not just biologically, but ceremonially. The honest answer: it depends where you look, and there isn't enough data. The International Union for Conservation of Nature hasn't formally assessed B. caapi. Peer-reviewed papers on its wild population are thin on the ground. So most of what we know comes from ethnographers, working ayahuasqueros, journalists, and the conservationists trying to sound an alarm. Here's what the picture looks like, region by region: The thread connecting all of this is straightforward. Where the vine is used by local communities at a community scale, it's been managed sustainably for centuries. The problems start when global demand collides with a slow-growing plant. There's also a knock-on effect most retreat-goers never hear about. A 2019 study in Conservation Biology linked the ayahuasca tourism boom to jaguar poaching — researchers interviewing vendors and people in the tourism industry traced demand for jaguar teeth, claws, and other parts back, in part, to spiritual-tourism markets. Sacred plants don't exist in a vacuum. When demand for a ceremony economy explodes, all sorts of unintended currents start flowing through the forest. This isn't an argument that ayahuasca tourism is inherently destructive. It isn't. But it does mean the choices a foreign visitor makes — which retreat, which lineage, which sourcing — ripple outward in ways the marketing copy will never describe. I'm not going to tell you to skip an ayahuasca retreat over conservation concerns. The medicine has helped a lot of people who had run out of other options — people working through addiction, depression, trauma loops that wouldn't quit. That's a real thing, and I won't pretend otherwise. But if you're going to drink the vine, you owe it a little curiosity about where it came from. A retreat center that genuinely cares about sustainability will be able to answer questions. The places that get squirrelly when you ask are telling you something. Here are the questions worth asking before you book: A retreat that grows its own vine, works with a known curandero lineage, and can talk plainly about its sourcing is doing more for your safety and your experience than one with prettier Instagram photos. Sustainability and quality tend to travel together. Sloppy sourcing usually means a sloppy operation. The vine of the soul has been quietly holding up a global movement — addiction recovery work, psychedelic-assisted healing experiments, the slow mainstreaming of plant medicine as a serious tool for people who've exhausted everything else. None of that happens without Banisteriopsis caapi, and none of it continues if the forest gives out. The honest truth is that the people drinking ayahuasca in retreat centers are, collectively, one of the major economic forces shaping what happens to the vine. That's not a guilt trip. It's leverage. The retreats that buyers reward — the ones with serious cultivation programs, transparent sourcing, and real relationships with indigenous stewards — are the ones that will define the next decade of this work. If any of this resonates and you're weighing your options seriously, a curated selection of ayahuasca retreats with vetted sourcing and lineage details can be browsed on our marketplace here. Choose carefully. The vine has been patient with us. The least we can do is return the favor.
Where to Find the Best Ayahuasca Retreats in 2026: A Region-by-Region Guide
Ask ten people who've sat with ayahuasca to describe it, and you'll get ten different answers. Profound. Brutal. Hilarious. Like a decade of therapy compressed into eight hours. Like meeting yourself for the first time. The vocabulary tends to escape people, which is part of why anyone considering an ayahuasca retreat does so much research before booking — there's no clean way to know what you're signing up for until you're in it. What you can research is where to go. The geography of ayahuasca has shifted dramatically over the last decade. What used to be a journey reserved for the Peruvian Amazon is now a global network of ceremony spaces — some traditional, some hybrid, some questionable. This guide walks through the regions worth knowing about in 2026, what makes each one different, and the kinds of questions you should be asking before you hand over a deposit. It's not a vacation. I want to be blunt about that because the word "retreat" carries spa-day baggage that doesn't fit. Yes, many centers have beautiful grounds, good food, and hammocks under palm trees. But the core experience — the ceremony itself — is closer to surgery than to a weekend getaway. The brew tastes terrible. You will probably purge. You may meet the parts of yourself you've spent years avoiding. That's the point. People come to ayahuasca for different reasons. Some are wrestling with addiction, depression, PTSD, or grief that won't shift. Others are not in crisis at all — they're curious about consciousness, or feel stuck, or want to understand a tradition they've read about for years. Both are legitimate. The plant doesn't really care about your reason. It tends to show you whatever you most need to see, which is rarely what you came expecting. A good retreat acknowledges all of this upfront. A great one screens you for medical and psychiatric contraindications before you even pay, prepares you with a proper dieta, and — crucially — gives you tools to integrate afterward. Skip the integration piece and you risk turning a powerful experience into an expensive blur. If authenticity matters to you, this is the region to look at first. The Amazon basin is where ayahuasca originated, where the lineages are still intact, and where the maestros and curanderas you've read about actually live and work. The trade-off is logistical: longer flights, more remote locations, and a level of rusticity that some people love and others find rough. Peru is the spiritual home of ayahuasca. Iquitos, Tarapoto, Pucallpa, and the Sacred Valley near Cusco all host serious centers. The Shipibo lineage — known for their icaros, the medicine songs sung during ceremony — is particularly well represented around the Ucayali river region. Centers run by or in genuine partnership with Shipibo curanderas tend to be the gold standard for traditional practice. What to expect: deeper jungle immersion, longer programs (seven to twelve days is common), and a stricter dieta both before and during the retreat. The food is simple — often plantain, fish, and rice with no salt, sugar, oil, or spice. The accommodations range from rustic tambo huts to comfortable lodges. Costs typically run anywhere from $1,500 to $4,000 for a week-plus stay, which is a fraction of what you'd pay closer to home. Costa Rica has become the entry point for a lot of first-timers who want a credible ceremony space without going deep into the Amazon. The country has stable infrastructure, easier flights from North America, and several well-regarded centers that import Shipibo healers from Peru rather than working with local facilitators. The result is a kind of hybrid: traditional ceremony, more comfortable surroundings, and stronger emphasis on Western-style preparation and integration support. Expect to pay more here — often $3,000 to $5,000 for a week — but the gap is partly justified by the level of psychological screening and aftercare that the better centers provide. If this is your first time and the idea of the deep jungle feels like too much, Costa Rica is a reasonable middle path. Mexico, especially the Yucatán and Riviera Maya, has a growing ceremony scene that blends ayahuasca with other plant medicines like temazcal sweat lodges and bufo. Colombia, particularly around the Sierra Nevada and the Putumayo region, hosts ceremonies led by taita healers from the Cofán and Inga traditions, which use a yagé preparation slightly different from the Peruvian style. Twenty years ago, almost nobody was sitting with ayahuasca in Europe. Today it's one of the fastest-growing regions for ceremony work, driven partly by the cost and hassle of flying to South America and partly by a quietly evolving legal landscape. The plant exists in a gray zone in much of Europe — DMT is controlled, but the brew itself isn't always explicitly named in legislation, and several centers operate under religious-use frameworks. The Dutch psychedelic scene is the most developed in Europe. Amsterdam is famous for legal psilocybin truffle retreats, and ayahuasca ceremonies operate in a tolerated gray area near major cities. Several long-running centers offer ceremonies with facilitators who've apprenticed in Peru, plus structured preparation calls and group integration afterward. If you want a credible ceremony space within a short flight of most European cities, the Netherlands is probably the easiest option. Both countries have decriminalized personal drug use, which has created space for ceremony work to develop more openly than elsewhere in Europe. The Iberian peninsula tends to attract a slower, more contemplative style of retreat — often combined with yoga, vegetarian cooking, and longer integration windows. Centers in Andalucía, the Algarve, and rural Portugal frequently work with visiting Peruvian maestros, blending traditional ceremony with the comforts of a European country estate. Region matters less than the people running the place. I've sat in mediocre ceremonies in legendary jungle lodges and extraordinary ones in unassuming farmhouses. Here's what I'd look at before booking anywhere: A serious retreat will cost you between $1,500 and $6,000 depending on region, length, and amenities. Add flights, travel days, and time off work, and the real number climbs. People sometimes balk at this, then spend the same amount on a beach holiday they'll forget within a year. Whether it's worth it depends entirely on what you're bringing and what you do afterward. I've watched people get a year of insight from one ceremony and waste it within a month by going straight back to old patterns. I've watched others have a relatively mild experience that quietly rewired how they relate to a parent, a partner, or themselves. The plant is one part of the equation. You are the rest of it. If you've read this far, you're already taking the decision seriously, which is the right starting place. Talk to people who've sat with the medicine. Ask hard questions of any center you're considering. Don't book the cheapest option, and don't book the most expensive one just because it looks beautiful on Instagram. For readers who want to start comparing specific ayahuasca retreats across these regions, a curated selection can be browsed on our marketplace here. Whatever you decide, give yourself enough time on the other side to actually absorb what happened. That part matters more than where you went.
The DEA vs. Ayahuasca: How a Flawed Federal Report Tried to Reshape the Conversation
Somewhere in a federal filing cabinet sat a document the public wasn't supposed to see for a long time. It took two Freedom of Information Act requests and the better part of two years before the DEA finally handed it over — a report titled Ayahuasca: Risks to Public Health and Safety, dated July 2020. Once it surfaced, the scientific community read it, raised eyebrows, and then sharpened their pens. If you're researching ayahuasca seriously — maybe weighing a retreat in Peru, maybe wondering whether the legal grey zone in the U.S. is shifting — this story matters. It tells you a lot about why ayahuasca occupies the strange position it does in American law, why research has been so slow despite mounting evidence of therapeutic benefit, and why the regulatory landscape isn't likely to shift overnight. Knowing this context changes how you think about plant medicine, about master plants, and about the whole machinery surrounding psychedelics and addiction recovery in the West. The report came out of an internal DEA review and landed firmly on the prohibitionist side of the ledger. Its core claim: ayahuasca poses a meaningful risk to public health and safety. That framing matters because it props up the federal classification of DMT — the active alkaloid in the brew — as a Schedule I substance. Schedule I, in DEA parlance, means a drug with high abuse potential and no accepted medical use. The agency has long argued that ayahuasca is essentially a delivery vehicle for DMT, which is how it justifies the same legal treatment. The trouble is, the report leaned heavily on a curated stack of references that supported its conclusions while leaving out a striking amount of contrary evidence. There was no mention, for instance, of the first randomized controlled trial of ayahuasca for treatment-resistant depression — a study that suggested both reasonable tolerability and meaningful clinical benefit. There was scant engagement with decades of epidemiological data from Indigenous Amazonian communities and the Brazilian religious churches (Santo Daime, União do Vegetal) where ayahuasca has been consumed ceremonially for generations without the public-health catastrophe the agency seems to anticipate. In other words: the science was selective. Not absent, just trimmed. In June 2023, the Chacruna Institute — together with scholars across biology, neuroscience, psychiatry, anthropology, and sociology — published a formal critique in the Journal of Psychedelic Studies. The article walked through the DEA report point by point, documenting factual omissions, theoretical assumptions presented as established fact, and what looked an awful lot like confirmation bias dressed up in citations. A few of the rebuttal's sharpest threads: The point of the critique wasn't to declare ayahuasca a miracle cure. It was to insist that policy this consequential should rest on a complete reading of the evidence, not a partial one. Here's where the abstract policy fight touches the ground. If you're a person in the U.S. researching ayahuasca because nothing else has worked for your depression, your drinking, your PTSD — the federal stance on plant medicine is a big part of why you're probably looking at a retreat in Peru, Costa Rica, or Brazil rather than a clinic in Colorado. The Schedule I classification creates real downstream effects. Research funding is harder to secure. Clinical trials face procedural hurdles that drugs in other categories don't. Therapists who might otherwise help with integration work risk their licenses if they get too close to the substance itself. And practitioners who run ceremonies in the U.S. — outside the narrow religious exemptions granted to the UDV in 2006 and to Santo Daime shortly after — operate in legal jeopardy. That's the landscape you're navigating when you start comparing retreat centers. The retreat industry that's grown up in Latin America exists in part because of these federal blockages. Many facilitators are themselves U.S. expats who relocated precisely because they couldn't practice openly at home. Short answer: not soon. The agency's mandate is enforcement, not research advocacy. Drug scheduling decisions technically flow from a coordinated process involving the FDA, but the DEA has historically resisted descheduling petitions even when the underlying science had moved on. The most-cited example is cannabis — twenty-five-plus years of state-level legalization, mounting clinical data, and federal scheduling has barely budged. A few realistic paths forward, in rough order of likelihood: For now, the gap between what the research suggests about plant medicine and addiction recovery — and what U.S. policy permits — remains wide. The Chacruna rebuttal won't close it by itself, but it's the kind of scholarship that eventually changes minds in the rooms where these decisions get made. If you've read this far, you're the kind of person who wants to make an informed decision rather than just chase a transformative-sounding weekend. A few honest pointers, born out of the policy reality above: The DEA's report tried to flatten a complex picture into a single warning label. The peer-reviewed response did the harder work of holding multiple truths at once: yes, there are risks; yes, there is therapeutic promise; yes, the science deserves better than selective citation. That's the spirit you want to bring to your own research, too. If something in this piece resonates and you're ready to look at the practical side of things, a curated selection of ayahuasca and plant-medicine retreats can be browsed on our marketplace here. Take your time with the decision — the medicine isn't going anywhere, and the right setting matters more than the calendar does.
Ayahuasca Goes Global: What the Worldwide Boom Means for the Vine, the Cultures, and You
Twenty years ago, if you wanted to sit with ayahuasca, you flew to Iquitos or you knew someone who knew someone. Today there's a ceremony happening tonight, probably within driving distance of wherever you're reading this. That shift — from sacred regional medicine to global phenomenon — is the single biggest story in plant medicine right now. And almost nobody talks about it honestly. I want to walk you through what ayahuasca's globalization actually looks like in 2026: the legal patchwork, the Brazilian church tradition that most retreat-seekers have never heard of, the uncomfortable colonial questions baked into psychedelic tourism, and what all of this means if you're sitting at your laptop right now wondering whether to book a retreat. This isn't a hype piece. It's the conversation I wish someone had with me before my first ceremony. Ayahuasca isn't a Peruvian thing. Or a Brazilian thing. Or any single thing. It's a brew — usually Banisteriopsis caapi vine combined with a DMT-containing leaf like chacruna — used by dozens of distinct Indigenous Amazonian peoples for who-knows-how-many centuries. Each lineage has its own songs, its own dietary protocols, its own cosmology. Lumping them together is like saying all of Europe practices "European religion." What changed in the 20th century was the emergence of Brazilian ayahuasca churches: Santo Daime in the 1930s, Barquinha shortly after, and the União do Vegetal (UDV) in the 1960s. These groups braided ayahuasca use with Christian symbolism, African-Brazilian spiritual influences, and folk Catholicism. They built something genuinely new — a sacrament-based religious practice that travels well across borders. Brazil banned the brew briefly in 1985, then walked it back after the UDV requested a formal review. A working group spent two years visiting churches, interviewing leaders, reading the science. They concluded ayahuasca was a legitimate religious practice and lifted the ban for good. By 2010 the Brazilian government had reaffirmed the right of religious use under principles of religious freedom and protection of Indigenous and African-Brazilian cultural traditions. Heritage agencies began processes to recognize ayahuasca as intangible cultural patrimony. It's a remarkable arc — drug policy slowly giving way to cultural-heritage policy. Here's the part that surprises most people: there are two ayahuasca-using religious organizations operating legally in the United States. The UDV won a unanimous Supreme Court decision in 2006 protecting their sacramental use under the Religious Freedom Restoration Act. Santo Daime followed with a federal court win shortly after. Both organizations operate openly, ship the brew across state lines under religious exemption, and conduct ceremonies in cities you've heard of. That does NOT mean ayahuasca is generally legal in the U.S. The DMT in it is still Schedule I. The exemptions are narrow, granted to specific religious organizations after years of expensive litigation. Independent shamans, weekend ceremony groups, and most of the "retreat in a rented Airbnb" operations you see advertised on Instagram exist in a legal grey zone that's mostly tolerated until it isn't. People have been raided. People have done prison time. So when somebody asks me is ayahuasca legal where I live? — the honest answer is: probably not, with carve-outs that depend on the country, the state, the specific church, and the political weather. Europe has tightened considerably in recent years; the rate of arrests and prosecutions there has been climbing in a way that should give anyone pause. Brazil and Peru remain the most permissive. The U.S. sits somewhere in between, paradoxically more open than most of Europe because of its religious-freedom framework. The world ayahuasca diaspora — that's the term researchers use — has been gathering speed since the 1990s. People from the Global North fly to the Amazon, drop somewhere between $1,500 and $5,000 on a week-long retreat, drink the brew three to six times, and fly home. For many of them, including me on a first trip a long time ago, the experience is genuinely useful. For some, it's life-changing. For a small number, it's seriously destabilizing in ways the brochure didn't mention. But the broader picture is more complicated than the personal one. The boom has produced real consequences in source countries: None of this means you shouldn't go. It means you should go with eyes open. The most important single question to ask a prospective retreat: what is your relationship to the local community, and how do they benefit from your presence here? If the answer is vague or defensive, that tells you something. One of the reasons readers find articles like this one is that they're quietly considering plant medicine for something specific — addiction, depression, trauma, a stuck pattern that talk therapy hasn't budged. The research on ayahuasca for these conditions is genuinely promising. Small but well-designed studies have shown meaningful reductions in depression scores, improvements in PTSD symptoms, and substantial drops in substance use among ceremony participants. The mechanism appears to involve both the neurochemistry of DMT and the structured introspective process the ceremony provides. That said, ayahuasca is one of several so-called master plants in Amazonian tradition — others include tobacco (the strong jungle kind, not cigarettes), San Pedro, and various tree barks used in extended dietas. Calling them "master plants" reflects a worldview where the plant itself is the teacher and the ceremony is the classroom. Whether you take that literally or treat it as a useful metaphor, the framing matters. People who approach ayahuasca as a one-shot fix usually leave disappointed. People who approach it as the start of a longer relationship with their own healing tend to get more out of it. For addiction specifically, the picture is more nuanced than headlines suggest. Ibogaine has more dramatic acute effects on opioid withdrawal. Ayahuasca seems to work more slowly, through repeated exposure and the integration of insight over months. Neither is a magic bullet. Both work better when the person comes in already committed to changing something, with support waiting for them when they get home. If you've read this far, you're probably actually considering booking something. Here's what I tell friends who ask: Cost varies wildly. A modest Peruvian retreat run by a local family might run $1,200 for a week. A polished Western-facing operation with chefs and yoga decks can easily clear $5,000. Price is not a reliable proxy for safety or authenticity in either direction. The cheapest places sometimes cut corners on medical screening; the most expensive sometimes deliver a sanitized experience that's more spa than ceremony. The genie isn't going back in the bottle. Ayahuasca is going to keep spreading. The question is whether it spreads in ways that respect the source cultures and produce genuinely good outcomes for participants, or whether it gets ground down into another wellness commodity, sold next to cold plunges and breathwork classes. Both futures are still live possibilities. What I find quietly hopeful is the slow, unglamorous work happening on multiple fronts: legal advocacy for religious-use exemptions, conservation projects for caapi vine cultivation, ethical frameworks for benefit-sharing with Indigenous communities, integration networks for people coming back from ceremonies, and serious clinical research being done in partnership with — not extraction from — traditional knowledge holders. That work doesn't make headlines. It's how a real psychedelic culture gets built. If you're weighing a decision right now, take your time. Read more than one perspective. Talk to people who've gone, including the ones who had hard experiences. And if you want to compare reputable ayahuasca retreats with transparent intake processes, integration support, and clear ties to their host communities, a curated selection can be browsed on our marketplace here. The medicine has been around for centuries. It'll wait until you're ready.
Dreaming of a Psychedelic Retreat?
We have the best deals and offers from thousands of organizers all over the world! Get them into your mailbox every week!
We value your privacy. Your email address will never be shared or published.
